GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Panacea Life Sciences Holdings Inc (OTCPK:PLSH) » Definitions » Days Inventory

PLSH (Panacea Life Sciences Holdings) Days Inventory : 815.21 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Panacea Life Sciences Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Panacea Life Sciences Holdings's Average Total Inventories for the three months ended in Jun. 2024 was $4.05 Mil. Panacea Life Sciences Holdings's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.45 Mil. Hence, Panacea Life Sciences Holdings's Days Inventory for the three months ended in Jun. 2024 was 815.21.

The historical rank and industry rank for Panacea Life Sciences Holdings's Days Inventory or its related term are showing as below:

PLSH' s Days Inventory Range Over the Past 10 Years
Min: 437.21   Med: 1257.31   Max: 1522.72
Current: 1060.08

During the past 4 years, Panacea Life Sciences Holdings's highest Days Inventory was 1522.72. The lowest was 437.21. And the median was 1257.31.

PLSH's Days Inventory is ranked worse than
98.41% of 943 companies
in the Drug Manufacturers industry
Industry Median: 155.82 vs PLSH: 1060.08

Panacea Life Sciences Holdings's Days Inventory declined from Jun. 2023 (1,967.69) to Jun. 2024 (815.21).

Inventory Turnover measures how fast the company turns over its inventory within a year. Panacea Life Sciences Holdings's Inventory Turnover for the three months ended in Jun. 2024 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Panacea Life Sciences Holdings's Inventory-to-Revenue for the three months ended in Jun. 2024 was 3.45.


Panacea Life Sciences Holdings Days Inventory Historical Data

The historical data trend for Panacea Life Sciences Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Life Sciences Holdings Days Inventory Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Days Inventory
437.21 1,522.72 1,291.73 1,222.88

Panacea Life Sciences Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,967.69 2,054.26 961.77 944.91 815.21

Competitive Comparison of Panacea Life Sciences Holdings's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Life Sciences Holdings's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Days Inventory falls into.



Panacea Life Sciences Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Panacea Life Sciences Holdings's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

Days Inventory (A: Dec. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (4.449 + 4.014) / 2 ) / 1.263*365
=4.2315 / 1.263*365
=1,222.88

Panacea Life Sciences Holdings's Days Inventory for the quarter that ended in Jun. 2024 is calculated as:

Days Inventory (Q: Jun. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2024 ) + Total Inventories (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (4.063 + 4.031) / 2 ) / 0.453*365 / 4
=4.047 / 0.453*365 / 4
=815.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Life Sciences Holdings  (OTCPK:PLSH) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Panacea Life Sciences Holdings's Inventory Turnover for the three months ended in Jun. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Panacea Life Sciences Holdings's Inventory to Revenue for the three months ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Panacea Life Sciences Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Panacea Life Sciences Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Life Sciences Holdings Business Description

Traded in Other Exchanges
N/A
Address
5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. Its products are CBD Softgels, CBD Tablets, CBD Topicals, CBD Skin Care, CBD Tinctures, CBD Edibles, CBD Patches, CBD Pets, and PPE.
Executives
Leslie Buttorff director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 16194 W 45TH DRIVE, GOLDEN CO 80403
Janice Nerger director 5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121
Nathan Joel Berman officer: CONTROLLER & PRIN ACTNG OFCR 16194 W 45TH DRIVE, GOLDEN CO 80403
22nd Century Group, Inc. 10 percent owner 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Harvey J Kesner 10 percent owner 65 E. 55TH STREET, NEW YORK NY 10022
Lawrence Wert director 170 NUTTALL RD, RIVERSIDE IL 60546
Chesne Derek Du officer: Chief Growth Officer 80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Alvaro Daniel Alberttis director 80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483
Vladislav Yampolsky director, 10 percent owner 332 PLAZA REAL, BOCA RATON FL 33432
Steven A Schwartz director 332 PLAZA REAL, BOCA RATON FL 33432
Andrew L. Johnson officer: Chief Strategy Officer 80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483
Emiliano Angel Aloi officer: President 510 SUNSHINE DRIVE, DELRAY BEACH FL 33444
Jonathan Gilbert director, officer: Executive Chairman 36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577
John C Price director 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Kevin James Esval director NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019

Panacea Life Sciences Holdings Headlines

From GuruFocus

Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc.

By Stock market mentor Stock market mentor 01-23-2023